What does the Ashton Manual say about supplements?
The Ashton Manual says there is no general need for them. In Chapter III, under the heading “Diet, fluids and exercise”, Professor C. Heather Ashton wrote that “there is no general need for dietary supplements or extra vitamins or minerals or for ‘detoxifying’ measures”, and added in the next sentence, “All these can be harmful in excess.”
That is the whole position, and it is shorter than most people expect. The Manual does not name a vitamin to take, a mineral to avoid, or a dose of anything. It says a normal diet is enough and that more is not better.
Professor Ashton returned to the subject in the Ashton Manual Supplement, a set of later notes she added to the Manual from 2011 on (a supplement to the text, nothing to do with capsules). Her answer to the questions benzodiazepine users kept asking about which product would help was that “there is no evidence that nutritional supplements such as vitamins, minerals, amino acids etc. are helpful in benzodiazepine withdrawal.” So, why do so many articles and forum posts claim she said something more dramatic?
Professor Ashton did not say vitamins overstimulate the nervous system.
A claim circulates that Professor Ashton warned against vitamins because a withdrawing nervous system reacts paradoxically to them, and that she singled out B vitamins in particular. The Manual contains no such mechanism and no such warning. Ashton Manual Guide has checked the chapter and the Supplement, and the words are not there.
In fact, what she wrote is plainer and, in a way, more useful. There is no evidence that supplements help, there is no evidence that withdrawal creates a deficiency for them to correct, and some of them are harmful in excess. A reader does not need a theory of overstimulation to act on that.
The Supplement does make one specific point about pharmacology, and it concerns GABA, or gamma-aminobutyric acid, the brain’s main calming neurotransmitter. Its reasoning is that benzodiazepines alter the way GABA receptors work, not the amount of GABA the brain has. So, in Professor Ashton’s words, “taking GABA precursors does not increase GABA concentrations in the brain”, and a capsule labeled GABA is answering a question the withdrawing brain is not asking.
Does benzo withdrawal cause vitamin deficiencies?
The Manual’s answer is that there is no evidence it does. The Supplement states that there is no evidence “that suggests benzodiazepine withdrawal causes vitamin, mineral or other deficiencies”, and follows with the sentence that settles most supplement questions: “No-one should take supplements without clear evidence of a specific deficiency.”
Yet, clear evidence usually means a result on a test that a doctor has seen, not a symptom that matches a list on a website. Fatigue, poor sleep, and muscle tension sit on the list for withdrawal and on the list for a dozen deficiencies, which is exactly why the symptom alone proves nothing. A person with a documented deficiency has a medical reason to correct it, and that reason has nothing to do with the taper.
For everyone else, Chapter III describes the whole prescription. “A normal healthy diet which includes generous amounts of fruit and vegetables and a source of protein and fats,” Professor Ashton wrote, “and not too much pure sugar or ‘junk foods’, provides all the nutrients a person needs.” In the same passage she added that there is no need to drink extra water to flush out “impurities/toxins”, because the body already does that on its own. The advice is ordinary on purpose.
Some supplements may contain benzo-like substances.
This is the one warning in the Manual that goes beyond “unnecessary”. In the Supplement, Professor Ashton wrote that excessive doses of some supplements “can be toxic and others may even contain benzo-like substances that have the same adverse effects as benzodiazepines themselves.”
The reason it matters is worth stating in this site’s own words. A taper is a series of measured reductions in a drug that acts on GABA receptors. A product that acts on the same receptors, in an amount printed nowhere on the label, is an unmeasured dose added on top of the measured one, and the taper stops meaning what the schedule says it means.
The Supplement also lists products that people had tried and found, in her phrase, “at best useless, at worst harmful”. The list includes mineral and vitamin supplements, valerian, St. John’s Wort, kava-kava, melatonin, 5-HTP (or 5-hydroxytryptophan), and GABA itself.
She did not claim to have tested any of them, and neither has this site. The point is the pattern: the products sold for calm and sleep are the ones with the best chance of acting on the very system the taper is trying to settle.
Why do people reach for supplements anyway?
Because they feel terrible, and a bottle is something they can do today. The pattern is common enough to describe without naming anyone.
A person a few months into a taper hits a bad stretch, searches for help at two in the morning, finds a forum thread with a list of twelve products, and orders eight of them. Two weeks later the bad stretch is different, and there is no way to know whether any capsule made it better, made it worse, or did nothing at all.
There is a second reason, and it deserves respect. The benzodiazepine came from a doctor, with an assurance that it was safe, and the withdrawal came from following that advice. A health-food store can feel safer than another prescription.
Physical dependence on a prescribed medication is a medical condition and not addiction, and the wish to do something about the symptoms is not a weakness. Unfortunately, that same wish is what the supplement shelf is built to sell to. Professor Ashton’s answer to readers in that position was not a different bottle: the gradual taper is the treatment, and ordinary food is the diet.
A sensitized nervous system makes it hard to tell what a new product is doing.
What follows is clinical experience, which varies from person to person, and it is not in the Manual. Withdrawal symptoms rise and fall on their own, in the windows and waves that people in withdrawal describe, and a nervous system in this state reacts to small changes in ways that are hard to predict. Still, some people report that a product they tolerated for years now leaves them wired or flattened, and others notice nothing at all.
Imagine trying to decide whether a new light bulb flickers while the power to the whole house keeps surging and dipping. Whatever the bulb is doing is lost in the noise, and the sensible move is to stop adding bulbs until the supply steadies. The analogy is not perfect, but withdrawal is the unsteady supply.
So, the fewer new things added during a taper, the clearer the picture of what the taper itself is doing. When several products go in at once and a bad week follows, the usual response is to add another product, or to blame the taper and speed it up. Neither follows from any evidence, and the Manual’s advice to change little and eat normally has the quiet benefit of keeping the picture clear.
Any supplement is a prescriber conversation.
Nothing in this article says that a person tapering a benzodiazepine may never swallow a vitamin. It says that the Manual gives no reason to, that some products may act like the drug being tapered, and that no reader can tell from a label which ones. That is a question for the prescriber who is supervising the taper, and it is worth asking before the first capsule rather than after a bad two weeks.
The useful version of the conversation is concrete. Bring the bottles, or a photo of the labels, and ask two things: whether there is a documented reason to take this, and whether anything in it acts on GABA receptors or interacts with the benzodiazepine.
If a product already in daily use turns out to contain something benzo-like, it belongs inside the taper plan rather than being dropped overnight, and that is the prescriber’s call too. A seizure, or any symptom that feels like a medical emergency during a taper, is a call to emergency services, not a supplement question.
The taper itself is where the work happens. The Manual’s method is a gradual, stepwise reduction, paced by the person taking it, with holds when they are needed, and the shape of a schedule like that can be seen on the benzodiazepine taper calculator, which is an educational planning tool and not a schedule for any one reader.
What the Manual asks a person to leave out is a shorter list than what it asks them to leave in. Alcohol acts on the same receptors as the benzodiazepine, caffeine is a stimulant, and both are covered in this site’s article on caffeine and alcohol during a benzo taper. Everything else on the supplement shelf, the Manual leaves on the shelf.
Questions readers ask about supplements and the Ashton Manual.
Does the Ashton Manual recommend magnesium for benzo withdrawal?
No. The Manual names no vitamin or mineral as helpful, and the Supplement says there is no evidence that any of them are. Magnesium is a mineral, and the Manual’s line on minerals is that a normal diet supplies enough and that excess can be harmful. A documented low magnesium level is a different matter, and a prescriber can check for one.
Are herbal sleep aids like valerian or melatonin safe during a taper?
The Supplement lists valerian, kava-kava, and melatonin among the products people found “at best useless, at worst harmful”, and it warns that some supplements may even contain benzo-like substances. Whether a particular product is safe for a particular person is not something a label can answer. It belongs in the conversation with the prescriber supervising the taper, before it is started.
Can a GABA supplement replace what the benzodiazepine was doing?
No, and the Supplement explains why in one sentence: “taking GABA precursors does not increase GABA concentrations in the brain.” Benzodiazepines change how the GABA receptor responds, not how much GABA is present, so a GABA capsule does not reach the part that changed. What settles the receptor is time and a gradual taper, not a precursor.
This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.
